Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Pneumococcal vaccination in children at risk of developing recurrent acute otitis media - a randomized study.

Gisselsson-Solén M, Melhus A, Hermansson A.

Acta Paediatr. 2011 Oct;100(10):1354-8. doi: 10.1111/j.1651-2227.2011.02332.x. Epub 2011 May 27.

PMID:
21517964
2.

The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea.

Stamboulidis K, Chatzaki D, Poulakou G, Ioannidou S, Lebessi E, Katsarolis I, Sypsa V, Tsakanikos M, Kafetzis D, Tsolia MN.

Pediatr Infect Dis J. 2011 Jul;30(7):551-5. doi: 10.1097/INF.0b013e31821038d9.

PMID:
21297521
3.
4.

Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):253-7.

5.

Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age.

Prymula R, Kriz P, Kaliskova E, Pascal T, Poolman J, Schuerman L.

Vaccine. 2009 Dec 10;28(1):71-8. doi: 10.1016/j.vaccine.2009.09.113. Epub 2009 Oct 8.

PMID:
19818722
6.

Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.

Grijalva CG, Nuorti JP, Griffin MR.

JAMA. 2009 Aug 19;302(7):758-66. doi: 10.1001/jama.2009.1163.

7.

Prevention of otitis media: now a reality?

Schuerman L, Borys D, Hoet B, Forsgren A, Prymula R.

Vaccine. 2009 Sep 25;27(42):5748-54. doi: 10.1016/j.vaccine.2009.07.070. Epub 2009 Aug 8. Review.

PMID:
19666154
8.

Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.

Rodgers GL, Arguedas A, Cohen R, Dagan R.

Vaccine. 2009 Jun 12;27(29):3802-10. doi: 10.1016/j.vaccine.2009.04.021. Epub 2009 Apr 25. Review.

PMID:
19446378
9.

How to compare the efficacy of conjugate vaccines to prevent acute otitis media?

De Wals P, Erickson L, Poirier B, Pépin J, Pichichero ME.

Vaccine. 2009 May 11;27(21):2877-83. doi: 10.1016/j.vaccine.2009.02.102. Epub 2009 Mar 10. Review.

PMID:
19366579
10.

Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy.

Durando P, Crovari P, Ansaldi F, Sticchi L, Sticchi C, Turello V, Marensi L, Giacchino R, Timitilli A, Carloni R, Azzari C, Icardi G; Collaborative Group for Pneumococcal Vaccination in Liguria.

Vaccine. 2009 May 26;27(25-26):3459-62. doi: 10.1016/j.vaccine.2009.01.052. Epub 2009 Feb 5.

PMID:
19200823
11.

Impact of different case definitions for acute otitis media on the efficacy estimates of a pneumococcal conjugate vaccine.

Palmu A, Jokinen J, Kilpi T; Finnish Otitis Media Study Group.

Vaccine. 2008 May 12;26(20):2466-70. doi: 10.1016/j.vaccine.2008.03.013. Epub 2008 Mar 31.

PMID:
18420315
12.

Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.

Zhou F, Shefer A, Kong Y, Nuorti JP.

Pediatrics. 2008 Feb;121(2):253-60. doi: 10.1542/peds.2007-0619.

PMID:
18245415
13.

Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among Navajo and White Mountain Apache infants.

O'Brien KL, David AB, Chandran A, Moulton LH, Reid R, Weatherholtz R, Santosham M.

Pediatr Infect Dis J. 2008 Jan;27(1):71-3.

PMID:
18162944
14.

Brief review of the clinical effectiveness of PREVENAR against otitis media.

Fletcher MA, Fritzell B.

Vaccine. 2007 Mar 22;25(13):2507-12. Epub 2006 Sep 20. Review.

PMID:
17011085
15.

National, state, and urban area vaccination coverage among children aged 19-35 months--United States, 2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2006 Sep 15;55(36):988-93.

16.

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.

Grijalva CG, Poehling KA, Nuorti JP, Zhu Y, Martin SW, Edwards KM, Griffin MR.

Pediatrics. 2006 Sep;118(3):865-73.

PMID:
16950975
17.

Pneumococcal vaccination for acute otitis media.

Arguedas A, Soley C.

Lancet. 2006 Jun 10;367(9526):1897-8; author reply 1898. No abstract available.

PMID:
16765749
18.

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.

Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L.

Lancet. 2006 Mar 4;367(9512):740-8.

PMID:
16517274
19.

Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine.

McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS, Schutze GE, Kim KS, Mason EO, Wald ER.

Clin Infect Dis. 2005 Jun 15;40(12):1738-44. Epub 2005 May 11.

PMID:
15909260
20.

Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.

Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E.

Pediatr Infect Dis J. 2004 Sep;23(9):829-33.

PMID:
15361721

Supplemental Content

Support Center